These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 31171769

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
    Sun G, Liu M, Han H.
    J Cell Physiol; 2019 Aug; 234(10):17824-17838. PubMed ID: 30993707
    [Abstract] [Full Text] [Related]

  • 23. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q, Zheng PS, Yang WT.
    Oncotarget; 2016 Jun 14; 7(24):36115-36129. PubMed ID: 27092879
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomas.
    Wang B, Sun F, Dong N, Sun Z, Diao Y, Zheng C, Sun J, Yang Y, Jiang D.
    Diagn Pathol; 2014 Nov 14; 9():211. PubMed ID: 25394492
    [Abstract] [Full Text] [Related]

  • 26. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
    Yang Y, Sun Y, Wu Y, Tang D, Ding X, Xu W, Su B, Gao W.
    Mol Carcinog; 2018 Jul 14; 57(7):842-853. PubMed ID: 29566281
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. LncRNA LINC00998 inhibits the malignant glioma phenotype via the CBX3-mediated c-Met/Akt/mTOR axis.
    Cai H, Yu Y, Ni X, Li C, Hu Y, Wang J, Chen F, Xi S, Chen Z.
    Cell Death Dis; 2020 Dec 02; 11(12):1032. PubMed ID: 33268783
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Downregulation of TET1 Promotes Glioma Cell Proliferation and Invasion by Targeting Wnt/β-Catenin Pathway.
    Ji J, You Q, Zhang J, Wang Y, Cheng J, Huang X, Zhang Y.
    Anal Cell Pathol (Amst); 2021 Dec 02; 2021():8980711. PubMed ID: 34926132
    [Abstract] [Full Text] [Related]

  • 36. A central role for MeCP2 in the epigenetic repression of miR-200c during epithelial-to-mesenchymal transition of glioma.
    Bian E, Chen X, Xu Y, Ji X, Cheng M, Wang H, Fang Z, Zhao B.
    J Exp Clin Cancer Res; 2019 Aug 20; 38(1):366. PubMed ID: 31429770
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. FAM84B acts as a tumor promoter in human glioma via affecting the Akt/GSK-3β/β-catenin pathway.
    Wang M, Li C, Shi W.
    Biofactors; 2021 Jul 20; 47(4):600-611. PubMed ID: 33759248
    [Abstract] [Full Text] [Related]

  • 39. Downregulation of miR-130a promotes cell growth and epithelial to mesenchymal transition by activating HMGB2 in glioma.
    Tang C, Yang Z, Chen D, Xie Q, Peng T, Wu J, Qi S.
    Int J Biochem Cell Biol; 2017 Dec 20; 93():25-31. PubMed ID: 28851665
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.